Cognitive Behavioural Therapy for Medicines Related Consultations.
Research type
Research Study
Full title
A Study to Investigate the Effect of Cognitive Behavioural-Based Therapy Techniques on Medicines Related Consultations, Healthcare Professional Work Satisfaction and Patient Beliefs About Medication, Adherence and Quality of Life.
IRAS ID
201634
Contact name
Lindsey Roberts
Contact email
Sponsor organisation
Health Education England Thames Valley
Duration of Study in the UK
1 years, 0 months, 1 days
Research summary
Concerns have been growing over the need to reduce risks for patients and help them derive maximum benefits from their medicines, so that best quality outcomes are achieved (1). Up to half of patients do not take their medicines as recommended (2) and only 16% of patients prescribed a new medicine take it as intended, experience no problems and receive enough information to enable them to take it correctly (3). When patients do not take their medicines in line with recommended advice it costs the NHS an estimated half a billion pounds a year in lost benefits (3). Poor adherence to medication is common, contributing to worsening of disease, death and increased healthcare costs (4).
Patient consultations are considered one of the key vehicles through which medicines optimisation and public health can be delivered. Healthcare professionals (HCP's) are aware of the need to overcome non-adherence in addition to providing patients with medicines information. With this in mind, a feasibility study was conducted with 20 community pharmacists trained in CBT methods. The training methods, content and suitability for clinical practice were evaluated and reported.
The objective of this study is to redesign, implement and evaluate an adaptation of the existing ’10-minute CBT’ training package accredited by the Royal College of General Practitioner (RCGP) to be suitable for wider use by a range of healthcare professionals (i.e. Practice Nurses, Community Pharmacists, Hospital Pharmacists as well as General Practitioners) to deliver enhanced Cognitive Behavioural Therapy (CBT) based medicines related consultations with patients.
The present study will be rolled out throughout the Oxford AHSN geography with 150 HCP trainees. The effect on patients (i.e. self-efficacy, adherence, quality of life and health outcomes) and healthcare professional (i.e. work satisfaction) will be evaluated to demonstrate the effectiveness of the intervention with approximately 1,500 patients.
REC name
London - Surrey Borders Research Ethics Committee
REC reference
16/LO/1778
Date of REC Opinion
22 Sep 2016
REC opinion
Favourable Opinion